大發地產(06111.HK)附屬擬1.95億元出售成都悦湖利鑫置業33%股權
格隆匯1月5日丨大發地產(06111.HK)發佈公吿,2022年1月4日,公司間接非全資子公司成都瀚維與廈門辰軒訂立股權轉讓協議,據此,廈門辰軒已同意收購目標公司33%股權,總對價約為人民幣1.95億元。
目標公司(即成都悦湖利鑫置業有限公司)為一家於中國成立的有限責任公司,其主要從事物業開發。目標公司的主要資產為湖光裏院項目,該項目為位於成都市的住宅物業,正在建設中。於該公吿日期,成都瀚維、成都和薩企業管理有限公司(公司的獨立第三方)及成都市保豐投資有限公司(公司的獨立第三方)分別直接持有目標公司的33%、34%及33%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.